Xcout Intel
FoRx Therapeutics
FoRx Therapeutics is a privately held clinical-stage biotechnology company headquartered in Basel, Switzerland. The company pioneers precision therapeutics targeting DNA Replication Stress in cancer treatment. Its office is located at Lichtstrasse 35, 4056 Basel, Switzerland.
Subscribe to see FoRx Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
FoRx Therapeutics at a glance
FoRx Therapeutics is a biotech company headquartered in Switzerland. Xcout tracks 9 named people at FoRx Therapeutics, including Tarig Bashir (Chief Executive Officer (CEO)).
FoRx Therapeutics leadership
- Tarig BashirChief Executive Officer (CEO)
- Michael KauffmanExecutive Chairman
- Robert BrownChairman of the Board
- Beat SteffenBoard Member
- Christian UhrichBoard Member
- Emily ChenBoard Member
3 more named people on record for FoRx Therapeutics, with roles, board committees and tenure — see the full roster →
FoRx Therapeutics competitors
A few of FoRx Therapeutics's closest competitors — see the full list of competitors and alternatives →
Fore Biotherapeutics is a virtual precision oncology company rooted in science and innovation, with expertise and talent across the USA. The company is focused on developing treatments, including its Plixorafenib Program.
DCx Biotherapeutics is a Canadian preclinical-stage biotechnology company developing precision oncology therapeutics and precision drug conjugates to target genetically defined cancers. The company focuses on addressing root drivers and key cellular interdependencies of cancer lesions.
Nested Therapeutics is a privately held biotech company headquartered in Cambridge, Massachusetts, focused on advancing precision oncology medicine by uncovering hidden driver mutations.
Tessellate Bio is a biotechnology company that develops precision oncology medicines by exploring synthetic lethal interactions beyond homologous recombination deficiency. The company integrates biomarker discovery and companion diagnostics into its research programs to create first-in-class treatments for hard-to-treat cancers.
Apeiron Therapeutics is a clinical-stage biopharmaceutical and precision oncology company focused on developing biomarker-driven therapeutics for cancer.
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Get FoRx Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on FoRx Therapeutics in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access